Folate (Vitamin B9)

Folate (vitamin B9) is a water-soluble B-vitamin that serves five critical roles: (1) DNA synthesis and repair — folate is required for the synthesis of purines and thymidine (nucleotide bases) via one-carbon metabolism; without folate, DNA replication is impaired; (2) cell division — rapidly dividing cells (bone marrow, fetal tissues, intestinal epithelium) are particularly folate-dependent; (3) neural tube development — folate is essential during the first 28 days after conception for the formation and closure of the neural tube (embryonic precursor to the brain and spinal cord); deficiency during this window causes spina bifida and anencephaly; (4) homocysteine remethylation — folate, via tetrahydrofolate (THF), is a cofactor for methionine synthase, which converts homocysteine to methionine; high homocysteine is an independent cardiovascular risk factor; (5) neurotransmitter synthesis — folate is required for the synthesis of dopamine, serotonin, and norepinephrine, making it essential for mood regulation and cognitive function.

Megaloblastic anaemia is the hallmark sign — folate deficiency impairs DNA synthesis, causing red blood cells to become large and immature (megaloblasts), reducing oxygen-carrying capacity and causing fatigue, weakness, and shortness of breath. Other early signs include mouth sores (glossitis), gastrointestinal symptoms (diarrhoea, loss of appetite), and elevated homocysteine. Neuropsychiatric symptoms include depression, irritability, anxiety, brain fog, poor concentration, and memory problems. In pregnancy, folate deficiency causes neural tube defects (spina bifida, anencephaly, cleft palate) during the first 28 days after conception — the window when the neural tube is closing. CRITICAL: Folate deficiency can mask B12 deficiency — if both are present and folate is repleted without B12, it can unmask and worsen irreversible B12-related neurological damage (subacute combined degeneration of the spinal cord, affecting gait, proprioception, and vibration sense).

The Recommended Dietary Allowance (RDA) is 400 mcg Dietary Folate Equivalent (DFE) per day for adult men and non-pregnant women. The requirement increases for pregnant women to 600 mcg DFE/day and for breastfeeding women to 500 mcg DFE/day. The FDA Daily Value is 400 mcg DFE. The Tolerable Upper Intake Level (UL) is 1,000 mcg/day of synthetic folic acid (not food folate), set to prevent masking of B12 deficiency — doses above 1,000 mcg/day of folic acid can make B12 deficiency symptoms less obvious whilst allowing neurological damage to progress silently. DFE units account for the superior bioavailability of synthetic folic acid vs. natural folate: 1 mcg DFE = 1 mcg food folate = 0.6 mcg synthetic folic acid.

The richest sources per serving are beef liver (215 mcg per 85 g / 3 oz cooked), lentils (358 mcg per 198 g / 1 cup cooked), asparagus (134 mcg per 134 g / ½ cup), spinach cooked (131 mcg per 90 g / ½ cup), black-eyed peas (105 mcg per 172 g / ½ cup cooked), avocado (59 mcg per medium fruit), and broccoli raw (57 mcg per 91 g / ½ cup). Fortified ready-to-eat cereals provide up to 400 mcg per serving (equivalent to the daily RDA in a single bowl). Folate is heat-sensitive and water-soluble — boiling vegetables in water leaches 50–95% of folate, whilst light steaming or sautéing for 2–3 minutes preserves most. Raw or lightly cooked vegetables maximise folate intake.

The neural tube (embryonic precursor to the brain and spinal cord) closes between days 21 and 28 after conception — often before a woman knows she is pregnant. Inadequate folate during this critical window causes neural tube defects (NTDs): spina bifida (incomplete closure of the spine, affecting 0.3–1 per 1,000 births in unprotected populations) and anencephaly (absence of major brain and skull portions, which is fatal). The landmark MRC Vitamin Study (1991, Lancet) and Czeizel et al. (1992, prevention trial) demonstrated that women taking 400 mcg folic acid daily reduced NTD risk by 50–70% compared to placebo. This evidence led to mandatory folic acid fortification of grain products in the USA (1998), Canada, and 50+ countries, reducing NTD rates by ~30–50%. The CDC recommends all women of reproductive age (15–45 years) take 400 mcg folic acid daily, starting at least 1 month before conception. Prenatal vitamins contain 400–800 mcg, and supplementation should continue throughout pregnancy.

Folate is the natural form of vitamin B9 found in food; it exists in polyglutamate form (multiple glutamic acid residues attached), requiring hydrolysis by intestinal folate hydrolase before absorption. Bioavailability is ~50% of an equivalent synthetic dose. Folic acid is the synthetic, oxidised monoglutamate form found in supplements and fortified foods (added to grain products, cereals, fortified milks). Folic acid is directly absorbed without hydrolysis, yielding ~85–90% bioavailability — approximately 1.7× higher than food folate. This difference is why the "Dietary Folate Equivalent" (DFE) unit was created: 1 mcg DFE = 1 mcg food folate = 0.6 mcg synthetic folic acid. Both are converted in the body to the active form tetrahydrofolate (THF) and its methylated derivative 5-methyltetrahydrofolate (5-MTHF). People with MTHFR gene variants (common in ~10–15% of the population) may convert folic acid less efficiently; these individuals sometimes benefit from methylfolate (5-MTHF) supplements, though most still respond adequately to folic acid.

MTHFR (methylenetetrahydrofolate reductase) is an enzyme that converts folate to its active form, 5-methyltetrahydrofolate (5-MTHF). The most common genetic variants are C677T and A1298C, which reduce enzyme efficiency by 30–70%. Approximately 10–15% of the population carries two copies (homozygous) of the C677T variant, meaning ~60–70% reduced enzyme activity. These individuals may have higher homocysteine levels and might benefit from methylfolate (5-MTHF) supplements rather than folic acid. However: most people with MTHFR variants still respond adequately to standard folic acid supplementation if intake is sufficient. MTHFR testing is not routinely recommended by major health authorities. If you have high homocysteine, a history of neural tube defect-affected pregnancy, or recurrent pregnancy loss, discuss MTHFR testing and possibly methylfolate supplementation with your doctor — but standard folic acid remains the evidence-backed recommendation for NTD prevention.

Yes — there is strong epidemiological and mechanistic evidence that folate is essential for mood regulation and cognitive health. Folate deficiency is associated with depression in multiple studies; up to 30% of depressed patients show low folate status. Mechanistically, folate is a cofactor for the synthesis of dopamine, serotonin, and norepinephrine via the tetrahydrobiopterin (BH4) pathway; it also participates in one-carbon metabolism, providing methyl groups for neurotransmitter synthesis. High-dose methylfolate (5-MTHF, 15 mg/day) has been studied as an adjunct to antidepressants with positive results in some randomised trials. Low folate is also associated with increased dementia and cognitive decline risk in ageing populations. Adequate folate throughout life supports cognitive resilience and mood stability. Conversely, addressing folate deficiency can improve depressive symptoms in some individuals, especially those with documented deficiency or MTHFR variants.